Identification of calcium-modulating cyclophilin ligand as a human host restriction to HIV-1 release overcome by Vpu
Tóm tắt
Từ khóa
Tài liệu tham khảo
Strebel, K., Klimkait, T. & Martin, M.A. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 241, 1221–1223 (1988).
Maldarelli, F., Chen, M.Y., Willey, R.L. & Strebel, K. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J. Virol. 67, 5056–5061 (1993).
Willey, R.L., Maldarelli, F., Martin, M.A. & Strebel, K. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 66, 7193–7200 (1992).
Terwilliger, E.F., Cohen, E.A., Lu, Y.C., Sodroski, J.G. & Haseltine, W.A. Functional role of human immunodeficiency virus type 1 vpu. Proc. Natl. Acad. Sci. USA 86, 5163–5167 (1989).
Margottin, F. et al. A novel human WD protein, h-β TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1, 565–574 (1998).
Bai, C. et al. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86, 263–274 (1996).
Schubert, U., Clouse, K.A. & Strebel, K. Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes. J. Virol. 69, 7699–7711 (1995).
Klimkait, T., Strebel, K., Hoggan, M.D., Martin, M.A. & Orenstein, J.M. The human immunodeficiency virus type 1–specific protein vpu is required for efficient virus maturation and release. J. Virol. 64, 621–629 (1990).
Schwartz, M.D., Geraghty, R.J. & Panganiban, A.T. HIV-1 particle release mediated by Vpu is distinct from that mediated by p6. Virology 224, 302–309 (1996).
Varthakavi, V., Smith, R.M., Bour, S.P., Strebel, K. & Spearman, P. Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production. Proc. Natl. Acad. Sci. USA 100, 15154–15159 (2003).
Abada, P., Noble, B. & Cannon, P.M. Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production. J. Virol. 79, 3627–3638 (2005).
Gottlinger, H.G., Dorfman, T., Cohen, E.A. & Haseltine, W.A. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc. Natl. Acad. Sci. USA 90, 7381–7385 (1993).
Bour, S. & Strebel, K. The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses. J. Virol. 70, 8285–8300 (1996).
Varthakavi, V. et al. The pericentriolar recycling endosome plays a key role in Vpu-mediated enhancement of HIV-1 particle release. Traffic 7, 298–307 (2006).
Bram, R.J. & Crabtree, G.R. Calcium signalling in T cells stimulated by a cyclophilin B–binding protein. Nature 371, 355–358 (1994).
Tran, D.D. et al. CAML is a p56Lck-interacting protein that is required for thymocyte development. Immunity 23, 139–152 (2005).
Tran, D.D., Russell, H.R., Sutor, S.L., van Deursen, J. & Bram, R.J. CAML is required for efficient EGF receptor recycling. Dev. Cell 5, 245–256 (2003).
Neil, S.J., Eastman, S.W., Jouvenet, N. & Bieniasz, P.D. HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane. PLoS Pathog. 2, e39 (2006).
Callahan, M.A. et al. Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel member of the tetratricopeptide repeat protein family. J. Virol. 72, 5189–5197 (1998).
Yao, X.J., Gottlinger, H., Haseltine, W.A. & Cohen, E.A. Envelope glycoprotein and CD4 independence of vpu-facilitated human immunodeficiency virus type 1 capsid export. J. Virol. 66, 5119–5126 (1992).
Cervantes-Acosta, G., Cohen, E.A. & Lemay, G. Human Jurkat lymphocytes clones differ in their capacity to support productive human immunodeficiency virus type 1 multiplication. J. Virol. Methods 92, 207–213 (2001).
Garrus, J.E. et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107, 55–65 (2001).
Martin-Serrano, J., Zang, T. & Bieniasz, P.D. Role of ESCRT-I in retroviral budding. J. Virol. 77, 4794–4804 (2003).
Tanzi, G.O., Piefer, A.J. & Bates, P. Equine infectious anemia virus utilizes host vesicular protein sorting machinery during particle release. J. Virol. 77, 8440–8447 (2003).
Strack, B., Calistri, A., Craig, S., Popova, E. & Gottlinger, H.G. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114, 689–699 (2003).
Neil, S.J., Zang, T. & Bieniasz, P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425–430 (2008).
Bartee, E., McCormack, A. & Fruh, K. Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog. 2, e107 (2006).
Feng, P. et al. Kaposi's sarcoma-associated herpesvirus mitochondrial K7 protein targets a cellular calcium-modulating cyclophilin ligand to modulate intracellular calcium concentration and inhibit apoptosis. J. Virol. 76, 11491–11504 (2002).
Tovey, S.C., Bootman, M.D., Lipp, P., Berridge, M.J. & Bram, R.J. Calcium-modulating cyclophilin ligand desensitizes hormone-evoked calcium release. Biochem. Biophys. Res. Commun. 276, 97–100 (2000).
Gomez, T.S. et al. HS1 functions as an essential actin-regulatory adaptor protein at the immune synapse. Immunity 24, 741–752 (2006).
Smith, A.J., Cho, M.I., Hammarskjold, M.L. & Rekosh, D. Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles. J. Virol. 64, 2743–2750 (1990).